GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Cyclically Adjusted PS Ratio

Egyptian International Pharmaceutical Investments (CAI:PHAR) Cyclically Adjusted PS Ratio : 1.40 (As of Jun. 09, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Egyptian International Pharmaceutical Investments's current share price is E£36.40. Egyptian International Pharmaceutical Investments's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was E£26.05. Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio for today is 1.40.

The historical rank and industry rank for Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio or its related term are showing as below:

CAI:PHAR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.97   Med: 1.32   Max: 1.86
Current: 1.4

During the past years, Egyptian International Pharmaceutical Investments's highest Cyclically Adjusted PS Ratio was 1.86. The lowest was 0.97. And the median was 1.32.

CAI:PHAR's Cyclically Adjusted PS Ratio is ranked better than
63.39% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs CAI:PHAR: 1.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Egyptian International Pharmaceutical Investments's adjusted revenue per share data for the three months ended in Dec. 2023 was E£10.424. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is E£26.05 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Egyptian International Pharmaceutical Investments Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Cyclically Adjusted PS Ratio Chart

Egyptian International Pharmaceutical Investments Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.56 1.23 1.40

Egyptian International Pharmaceutical Investments Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.09 1.10 1.35 1.40

Competitive Comparison of Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio falls into.



Egyptian International Pharmaceutical Investments Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=36.40/26.05
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egyptian International Pharmaceutical Investments's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Egyptian International Pharmaceutical Investments's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=10.424/129.4194*129.4194
=10.424

Current CPI (Dec. 2023) = 129.4194.

Egyptian International Pharmaceutical Investments Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3.120 99.695 4.050
201406 3.071 100.560 3.952
201409 3.019 100.428 3.891
201412 2.835 99.070 3.703
201503 3.423 99.621 4.447
201506 3.187 100.684 4.097
201509 3.405 100.392 4.390
201512 2.923 99.792 3.791
201603 3.784 100.470 4.874
201606 3.564 101.688 4.536
201609 4.028 101.861 5.118
201612 3.648 101.863 4.635
201703 4.620 102.862 5.813
201706 4.717 103.349 5.907
201709 4.861 104.136 6.041
201712 5.404 104.011 6.724
201803 5.678 105.290 6.979
201806 5.520 106.317 6.719
201809 5.291 106.507 6.429
201812 5.347 105.998 6.528
201903 7.099 107.251 8.566
201906 6.505 108.070 7.790
201909 6.596 108.329 7.880
201912 6.256 108.420 7.468
202003 5.972 108.902 7.097
202006 5.409 108.767 6.436
202009 5.568 109.815 6.562
202012 5.701 109.897 6.714
202103 6.208 111.754 7.189
202106 5.799 114.631 6.547
202109 6.797 115.734 7.601
202112 7.635 117.630 8.400
202203 7.193 121.301 7.674
202206 6.257 125.017 6.477
202209 7.392 125.227 7.640
202212 9.835 125.222 10.165
202303 7.697 127.348 7.822
202306 9.909 128.729 9.962
202309 9.486 129.860 9.454
202312 10.424 129.419 10.424

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Egyptian International Pharmaceutical Investments  (CAI:PHAR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Egyptian International Pharmaceutical Investments Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description

Traded in Other Exchanges
N/A
Address
1st Industrial Zone B1, EIPICO, 10th of Ramadan, EGY
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Headlines